Vor Biopharma Inc (NASDAQ: VOR): Do Not Miss The Gain Train

Vor Biopharma Inc (VOR) concluded trading on Thursday at a closing price of $2.37, with 0.48 million shares of worth about $1.14 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 12.86% during that period and on March 28, 2024 the price saw a gain of about 7.24%. Currently the company’s common shares owned by public are about 67.89M shares, out of which, 58.94M shares are available for trading.

However, the stock later moved at a day high price of 2.3800, or with a gain of 7.24%. Stock saw a price change of 20.92% in past 5 days and over the past one month there was a price change of 9.72%. Year-to-date (YTD), VOR shares are showing a performance of 5.33% which decreased to -56.83% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.62 but also hit the highest price of $5.80 during that period. The average intraday trading volume for Vor Biopharma Inc shares is 287.61K. The stock is currently trading 14.26% above its 20-day simple moving average (SMA20), while that difference is up 9.66% for SMA50 and it goes to -3.84% lower than SMA200.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Vor Biopharma Inc (NASDAQ: VOR) currently have 67.89M outstanding shares and institutions hold larger chunk of about 76.55% of that.

The stock has a current market capitalization of $161.56M and its 3Y-monthly beta is at -0.38. It has posted earnings per share of -$1.75 in the same period. It has Quick Ratio of 9.04 while making debt-to-equity ratio of 0.24. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for VOR, volatility over the week remained 8.08% while standing at 8.55% over the month.

Analysts are in expectations that Vor Biopharma Inc (VOR) stock would likely to be making an EPS of -$0.38 in the current quarter, while forecast for next quarter EPS is -$0.36 and it is -$1.3 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.42 which is -$0.34 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.43 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 18.03% while it is estimated to increase by 9.53% in next year.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wedbush on July 26, 2022 offering an Outperform rating for the stock and assigned a target price of $18 to it. Coverage by Goldman stated Vor Biopharma Inc (VOR) stock as a Neutral in their note to investors on April 27, 2022, suggesting a price target of $6 for the stock. On December 17, 2021, H.C. Wainwright Initiated their recommendations, while on December 03, 2021, Robert W. Baird Initiated their ratings for the stock with a price target of $38. Stock get an Outperform rating from Oppenheimer on December 02, 2021.

Most Popular

Related Posts